Status:
UNKNOWN
Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection
Lead Sponsor:
Ahmad Jabir Rahyussalim
Conditions:
Spinal Tuberculosis
Mesenchymal Stem Cell
Eligibility:
All Genders
15-64 years
Phase:
PHASE2
Brief Summary
This study evaluates the effectiveness of locally implantation of mesenchymal stem cell on vertebral bone defects due to infection of mycobacterium tuberculosis. there are controlled participants who ...
Detailed Description
Mesenchymal Stem Cell are implanted in Spinal Tuberculosis patient. MSC has inflammatory effect and the ability to form into new bone. In Spinal Tuberculosis, the spread of bacteria is commonly hemat...
Eligibility Criteria
Inclusion
- Clinicoradiologically diagnoses Spinal Tuberculosis
- receives Anti TB drugs
- minimun destruction 1/3 vertebral body
Exclusion
- patient under 15 years old
- reject to be included in the study
Key Trial Info
Start Date :
May 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04493918
Start Date
May 21 2017
End Date
December 30 2020
Last Update
August 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cipto Mangunkusumo Hospital
Jakarta Pusat, DKI Jakarta, Indonesia, 10430